Patents by Inventor Stefania Beato

Stefania Beato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical dosage forms
    Patent number: 10709691
    Abstract: The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or any pharmaceutically acceptable salt thereof and to processes of making said solid pharmaceutical dosage forms.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: July 14, 2020
    Assignee: RECORDATI AG
    Inventors: Stefania Beato, Peggy Quinton
  • PHARMACEUTICAL DOSAGE FORMS
    Publication number: 20190060283
    Abstract: The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or any pharmaceutically acceptable salt thereof and to processes of making said solid pharmaceutical dosage forms.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Inventors: Stefania Beato, Peggy Quinton
  • Pharmaceutical dosage forms
    Patent number: 10143680
    Abstract: The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or any pharmaceutically acceptable salt thereof and to processes of making said solid pharmaceutical dosage forms.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: December 4, 2018
    Assignee: Novartis AG
    Inventors: Stefania Beato, Peggy Quinton
  • PHARMACEUTICAL DOSAGE FORMS
    Publication number: 20170202808
    Abstract: The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile or any pharmaceutically acceptable salt thereof and to processes of making said solid pharmaceutical dosage forms.
    Type: Application
    Filed: July 6, 2015
    Publication date: July 20, 2017
    Inventors: Stefania BEATO, Peggy QUINTON
  • Anhydrous crystal form of ovrepitant maleate
    Patent number: 8309553
    Abstract: The invention relates to anhydrous crystalline orvepitant maleate (Form 1), pharmaceutical formulations comprising the same, its use in therapy and processes for preparing the same, wherein orvepitant is as shown in formula (I).
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: November 13, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stefania Beato, Franco Sartor, Ian Philip Steeples
  • Anhydrous Crystal Form Of Ovrepitant Maleate
    Publication number: 20110166150
    Abstract: The invention relates to anhydrous crystalline orvepitant maleate (Form 1), pharmaceutical formulations comprising the same, its use in therapy and processes for preparing the same.
    Type: Application
    Filed: April 9, 2009
    Publication date: July 7, 2011
    Inventors: Stefania Beato, Franco Sartor, Ian Philip Steeples
  • Compounds
    Publication number: 20080058398
    Abstract: The present invention relates to the tartrate salt of 1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane and solvates thereof, pharmaceutical formulations, processes for their preparation, and their use in medicine.
    Type: Application
    Filed: August 20, 2007
    Publication date: March 6, 2008
    Inventors: Clare Anderton, Sergio Bacchi, Stefania Beato, Franco Sartor